L-arginine  ||| S:0 E:11 ||| JJ
metabolism  ||| S:11 E:22 ||| JJ
enzyme  ||| S:22 E:29 ||| JJ
activities  ||| S:29 E:40 ||| NNS
in  ||| S:40 E:43 ||| IN
rat  ||| S:43 E:47 ||| JJ
liver  ||| S:47 E:53 ||| NN
subcellular  ||| S:53 E:65 ||| NN
fractions  ||| S:65 E:75 ||| NNS
under  ||| S:75 E:81 ||| IN
condition  ||| S:81 E:91 ||| NN
of  ||| S:91 E:94 ||| IN
protein  ||| S:94 E:102 ||| NN
deprivation  ||| S:102 E:114 ||| VBD
The  ||| S:114 E:118 ||| DT
features  ||| S:118 E:127 ||| NNS
of  ||| S:127 E:130 ||| IN
arginase  ||| S:130 E:139 ||| NN
and  ||| S:139 E:143 ||| CC
NO-synthase  ||| S:143 E:155 ||| JJ
pathways  ||| S:155 E:164 ||| NN
of  ||| S:164 E:167 ||| IN
arginine ||| S:167 E:175 ||| NN
's  ||| S:175 E:178 ||| POS
metabolism  ||| S:178 E:189 ||| NNS
have  ||| S:189 E:194 ||| VBP
been  ||| S:194 E:199 ||| VBN
studied  ||| S:199 E:207 ||| VBN
in  ||| S:207 E:210 ||| IN
rat  ||| S:210 E:214 ||| JJ
liver  ||| S:214 E:220 ||| NN
subcellular  ||| S:220 E:232 ||| NN
fractions  ||| S:232 E:242 ||| NNS
under  ||| S:242 E:248 ||| IN
condition  ||| S:248 E:258 ||| NN
of  ||| S:258 E:261 ||| IN
protein  ||| S:261 E:269 ||| NN
deprivation ||| S:269 E:280 ||| NN
.  ||| S:280 E:282 ||| .
During  ||| S:282 E:289 ||| IN
the  ||| S:289 E:293 ||| DT
experimental  ||| S:293 E:306 ||| JJ
period  ||| S:306 E:313 ||| NN
( ||| S:313 E:314 ||| -LRB-
28  ||| S:314 E:317 ||| CD
days ||| S:317 E:321 ||| NNS
)  ||| S:321 E:323 ||| -RRB-
albino  ||| S:323 E:330 ||| JJ
male  ||| S:330 E:335 ||| JJ
rats  ||| S:335 E:340 ||| NNS
were  ||| S:340 E:345 ||| VBD
kept  ||| S:345 E:350 ||| VBN
on  ||| S:350 E:353 ||| IN
semi  ||| S:353 E:358 ||| FW
synthetic  ||| S:358 E:368 ||| FW
casein  ||| S:368 E:375 ||| FW
diet  ||| S:375 E:380 ||| FW
AIN-93 ||| S:380 E:386 ||| FW
.  ||| S:386 E:388 ||| .
The  ||| S:388 E:392 ||| DT
protein  ||| S:392 E:400 ||| NN
deprivation  ||| S:400 E:412 ||| NN
conditions  ||| S:412 E:423 ||| NNS
were  ||| S:423 E:428 ||| VBD
designed  ||| S:428 E:437 ||| VBN
as  ||| S:437 E:440 ||| IN
total  ||| S:440 E:446 ||| JJ
absence  ||| S:446 E:454 ||| NN
of  ||| S:454 E:457 ||| IN
protein  ||| S:457 E:465 ||| NN
in  ||| S:465 E:468 ||| IN
the  ||| S:468 E:472 ||| DT
diet  ||| S:472 E:477 ||| NN
and  ||| S:477 E:481 ||| CC
consumption  ||| S:481 E:493 ||| NN
of  ||| S:493 E:496 ||| IN
the  ||| S:496 E:500 ||| DT
diet  ||| S:500 E:505 ||| NN
partially  ||| S:505 E:515 ||| RB
deprived  ||| S:515 E:524 ||| VBN
with  ||| S:524 E:529 ||| IN
1 ||| S:529 E:530 ||| CD
/ ||| S:530 E:531 ||| CD
2  ||| S:531 E:533 ||| CD
of  ||| S:533 E:536 ||| IN
the  ||| S:536 E:540 ||| DT
casein  ||| S:540 E:547 ||| JJ
amount  ||| S:547 E:554 ||| NN
compared  ||| S:554 E:563 ||| VBN
to  ||| S:563 E:566 ||| TO
in  ||| S:566 E:569 ||| IN
the  ||| S:569 E:573 ||| DT
regular  ||| S:573 E:581 ||| JJ
diet ||| S:581 E:585 ||| NN
.  ||| S:585 E:587 ||| .
Daily  ||| S:587 E:593 ||| JJ
diet  ||| S:593 E:598 ||| NN
consumption  ||| S:598 E:610 ||| NN
was  ||| S:610 E:614 ||| VBD
regulated  ||| S:614 E:624 ||| VBN
according  ||| S:624 E:634 ||| VBG
to  ||| S:634 E:637 ||| TO
the  ||| S:637 E:641 ||| DT
pair  ||| S:641 E:646 ||| NN
feeding  ||| S:646 E:654 ||| VBG
approach ||| S:654 E:662 ||| NN
.  ||| S:662 E:664 ||| .
It  ||| S:664 E:667 ||| PRP
has  ||| S:667 E:671 ||| VBZ
been  ||| S:671 E:676 ||| VBN
shown  ||| S:676 E:682 ||| VBN
that  ||| S:682 E:687 ||| IN
the  ||| S:687 E:691 ||| DT
changes  ||| S:691 E:699 ||| NNS
of  ||| S:699 E:702 ||| IN
enzyme  ||| S:702 E:709 ||| JJ
activities ||| S:709 E:719 ||| NNS
,  ||| S:719 E:721 ||| ,
involved  ||| S:721 E:730 ||| VBN
in  ||| S:730 E:733 ||| IN
L-arginine  ||| S:733 E:744 ||| JJ
metabolism ||| S:744 E:754 ||| NN
,  ||| S:754 E:756 ||| ,
were  ||| S:756 E:761 ||| VBD
characterized  ||| S:761 E:775 ||| VBN
by  ||| S:775 E:778 ||| IN
1.4-1.7  ||| S:778 E:786 ||| CD
fold  ||| S:786 E:791 ||| JJ
decrease  ||| S:791 E:800 ||| NN
in  ||| S:800 E:803 ||| IN
arginase  ||| S:803 E:812 ||| JJ
activity ||| S:812 E:820 ||| NN
,  ||| S:820 E:822 ||| ,
accompanied  ||| S:822 E:834 ||| VBN
with  ||| S:834 E:839 ||| IN
unchanged  ||| S:839 E:849 ||| JJ
NO-synthase  ||| S:849 E:861 ||| JJ
activity  ||| S:861 E:870 ||| NN
in  ||| S:870 E:873 ||| IN
cytosol ||| S:873 E:880 ||| NN
.  ||| S:880 E:882 ||| .
In  ||| S:882 E:885 ||| IN
mitochondrial  ||| S:885 E:899 ||| JJ
fraction  ||| S:899 E:908 ||| NN
the  ||| S:908 E:912 ||| DT
unchanged  ||| S:912 E:922 ||| JJ
arginase  ||| S:922 E:931 ||| JJ
activity  ||| S:931 E:940 ||| NN
was  ||| S:940 E:944 ||| VBD
accompanied  ||| S:944 E:956 ||| VBN
by  ||| S:956 E:959 ||| IN
3-5  ||| S:959 E:963 ||| CD
fold  ||| S:963 E:968 ||| JJ
increase  ||| S:968 E:977 ||| NN
of  ||| S:977 E:980 ||| IN
NO-synthase  ||| S:980 E:992 ||| JJ
activity ||| S:992 E:1000 ||| NN
.  ||| S:1000 E:1002 ||| .
At  ||| S:1002 E:1005 ||| IN
the  ||| S:1005 E:1009 ||| DT
terminal  ||| S:1009 E:1018 ||| NN
stages  ||| S:1018 E:1025 ||| NNS
of  ||| S:1025 E:1028 ||| IN
the  ||| S:1028 E:1032 ||| DT
experiment  ||| S:1032 E:1043 ||| NN
the  ||| S:1043 E:1047 ||| DT
monodirectional  ||| S:1047 E:1063 ||| JJ
dynamics  ||| S:1063 E:1072 ||| NNS
in  ||| S:1072 E:1075 ||| IN
the  ||| S:1075 E:1079 ||| DT
studied  ||| S:1079 E:1087 ||| JJ
activities  ||| S:1087 E:1098 ||| NNS
have  ||| S:1098 E:1103 ||| VBP
been  ||| S:1103 E:1108 ||| VBN
observed  ||| S:1108 E:1117 ||| VBN
in  ||| S:1117 E:1120 ||| IN
the  ||| S:1120 E:1124 ||| DT
mitochondrial  ||| S:1124 E:1138 ||| NN
and  ||| S:1138 E:1142 ||| CC
cytosolfractions  ||| S:1142 E:1159 ||| NN
in  ||| S:1159 E:1162 ||| IN
both  ||| S:1162 E:1167 ||| DT
experimental  ||| S:1167 E:1180 ||| JJ
groups ||| S:1180 E:1186 ||| NNS
.  ||| S:1186 E:1188 ||| .
In  ||| S:1188 E:1191 ||| IN
the  ||| S:1191 E:1195 ||| DT
studied  ||| S:1195 E:1203 ||| FW
subcellular  ||| S:1203 E:1215 ||| FW
fractions  ||| S:1215 E:1225 ||| FW
arginase  ||| S:1225 E:1234 ||| FW
activity  ||| S:1234 E:1243 ||| FW
decreased  ||| S:1243 E:1253 ||| FW
( ||| S:1253 E:1254 ||| -LRB-
2.4-2.7  ||| S:1254 E:1262 ||| NNP
fold  ||| S:1262 E:1267 ||| NN
with  ||| S:1267 E:1272 ||| IN
no  ||| S:1272 E:1275 ||| DT
protein  ||| S:1275 E:1283 ||| NN
in  ||| S:1283 E:1286 ||| IN
the  ||| S:1286 E:1290 ||| DT
diet  ||| S:1290 E:1295 ||| NN
and  ||| S:1295 E:1299 ||| CC
1.5  ||| S:1299 E:1303 ||| CD
fold  ||| S:1303 E:1308 ||| NN
with  ||| S:1308 E:1313 ||| IN
partly  ||| S:1313 E:1320 ||| RB
supplied  ||| S:1320 E:1329 ||| VBN
protein ||| S:1329 E:1336 ||| NN
)  ||| S:1336 E:1338 ||| -RRB-
and  ||| S:1338 E:1342 ||| CC
was  ||| S:1342 E:1346 ||| VBD
accompanied  ||| S:1346 E:1358 ||| VBN
by  ||| S:1358 E:1361 ||| IN
NO-synthase  ||| S:1361 E:1373 ||| JJ
activity  ||| S:1373 E:1382 ||| NN
increase  ||| S:1382 E:1391 ||| NN
by  ||| S:1391 E:1394 ||| IN
3.8  ||| S:1394 E:1398 ||| CD
fold  ||| S:1398 E:1403 ||| NN
in  ||| S:1403 E:1406 ||| IN
cytosole  ||| S:1406 E:1415 ||| JJ
fraction ||| S:1415 E:1423 ||| NN
,  ||| S:1423 E:1425 ||| ,
by  ||| S:1425 E:1428 ||| IN
7.2  ||| S:1428 E:1432 ||| CD
fold  ||| S:1432 E:1437 ||| NN
in  ||| S:1437 E:1440 ||| IN
mitochondrial  ||| S:1440 E:1454 ||| JJ
fraction  ||| S:1454 E:1463 ||| NN
in  ||| S:1463 E:1466 ||| IN
the  ||| S:1466 E:1470 ||| DT
group  ||| S:1470 E:1476 ||| NN
with  ||| S:1476 E:1481 ||| IN
no  ||| S:1481 E:1484 ||| DT
protein  ||| S:1484 E:1492 ||| NN
in  ||| S:1492 E:1495 ||| IN
the  ||| S:1495 E:1499 ||| DT
diet  ||| S:1499 E:1504 ||| NN
and  ||| S:1504 E:1508 ||| CC
by  ||| S:1508 E:1511 ||| IN
2.2  ||| S:1511 E:1515 ||| CD
and  ||| S:1515 E:1519 ||| CC
3.5  ||| S:1519 E:1523 ||| CD
fold  ||| S:1523 E:1528 ||| NN
in  ||| S:1528 E:1531 ||| IN
the  ||| S:1531 E:1535 ||| DT
group  ||| S:1535 E:1541 ||| NN
partialy  ||| S:1541 E:1550 ||| VBZ
supplied  ||| S:1550 E:1559 ||| VBN
with  ||| S:1559 E:1564 ||| IN
protein  ||| S:1564 E:1572 ||| NN
respectively ||| S:1572 E:1584 ||| RB
.  ||| S:1584 E:1586 ||| .
The  ||| S:1586 E:1590 ||| DT
observed  ||| S:1590 E:1599 ||| JJ
tendency  ||| S:1599 E:1608 ||| NN
is  ||| S:1608 E:1611 ||| VBZ
presumably  ||| S:1611 E:1622 ||| RB
caused  ||| S:1622 E:1629 ||| VBN
by  ||| S:1629 E:1632 ||| IN
the  ||| S:1632 E:1636 ||| DT
switch  ||| S:1636 E:1643 ||| NN
of  ||| S:1643 E:1646 ||| IN
L-arginine  ||| S:1646 E:1657 ||| JJ
metabolism  ||| S:1657 E:1668 ||| NN
from  ||| S:1668 E:1673 ||| IN
arginase  ||| S:1673 E:1682 ||| NN
into  ||| S:1682 E:1687 ||| IN
oxidizing  ||| S:1687 E:1697 ||| JJ
NO-synthase  ||| S:1697 E:1709 ||| JJ
parthway ||| S:1709 E:1717 ||| NN
.  ||| S:1717 E:1719 ||| .
